RhumbLine Advisers’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $405K | Buy |
21,186
+476
| +2% | +$8.27K | ﹤0.01% | 2892 |
|
|
2026
Q1 | $329K | Sell |
20,710
-1,463
| -7% | -$25.6K | ﹤0.01% | 2874 |
|
|
2025
Q4 | $394K | Sell |
22,173
-3,260
| -13% | -$57.1K | ﹤0.01% | 2809 |
|
|
2025
Q3 | $471K | Sell |
25,433
-407
| -2% | -$8.38K | ﹤0.01% | 2735 |
|
|
2025
Q2 | $555K | Buy |
25,840
+240
| +0.9% | +$5.19K | ﹤0.01% | 2623 |
|
|
2025
Q1 | $631K | Sell |
25,600
-811
| -3% | -$20K | ﹤0.01% | 2419 |
|
|
2024
Q4 | $612K | Buy |
26,411
+1,042
| +4% | +$26.1K | ﹤0.01% | 2536 |
|
|
2024
Q3 | $688K | Sell |
25,369
-1,244
| -5% | -$37.7K | ﹤0.01% | 2495 |
|
|
2024
Q2 | $765K | Buy |
26,613
+4,245
| +19% | +$130K | ﹤0.01% | 2391 |
|
|
2024
Q1 | $652K | Buy |
22,368
+513
| +2% | +$14.3K | ﹤0.01% | 2500 |
|
|
2023
Q4 | $710K | Buy |
21,855
+60
| +0.3% | +$1.74K | ﹤0.01% | 2464 |
|
|
2023
Q3 | $697K | Buy |
21,795
+924
| +4% | +$35.6K | ﹤0.01% | 2409 |
|
|
2023
Q2 | $915K | Buy |
20,871
+501
| +2% | +$23.1K | ﹤0.01% | 2339 |
|
|
2023
Q1 | $902K | Buy |
20,370
+1,182
| +6% | +$52.2K | ﹤0.01% | 2169 |
|
|
2022
Q4 | $762K | Buy |
19,188
+391
| +2% | +$16.3K | ﹤0.01% | 2271 |
|
|
2022
Q3 | $867K | Buy |
18,797
+2,316
| +14% | +$114K | ﹤0.01% | 2220 |
|
|
2022
Q2 | $711K | Buy |
16,481
+2,760
| +20% | +$126K | ﹤0.01% | 2315 |
|
|
2022
Q1 | $741K | Buy |
13,721
+865
| +7% | +$44.2K | ﹤0.01% | 2255 |
|
|
2021
Q4 | $770K | Sell |
12,856
-251
| -2% | -$15.6K | ﹤0.01% | 2323 |
|
|
2021
Q3 | $859K | Buy |
13,107
+569
| +5% | +$37K | ﹤0.01% | 2296 |
|
|
2021
Q2 | $792K | Sell |
12,538
-540
| -4% | -$31K | ﹤0.01% | 2345 |
|
|
2021
Q1 | $638K | Sell |
13,078
-1,045
| -7% | -$50.2K | ﹤0.01% | 2382 |
|
|
2020
Q4 | $583K | Buy |
14,123
+1,197
| +9% | +$54.9K | ﹤0.01% | 2381 |
|
|
2020
Q3 | $594K | Sell |
12,926
-1,850
| -13% | -$85.8K | ﹤0.01% | 2207 |
|
|
2020
Q2 | $647K | Buy |
14,776
+3,345
| +29% | +$150K | ﹤0.01% | 2228 |
|
|
2020
Q1 | $453K | Buy |
11,431
+661
| +6% | +$29.6K | ﹤0.01% | 2205 |
|
|
2019
Q4 | $506K | Buy |
10,770
+111
| +1% | +$4.3K | ﹤0.01% | 2356 |
|
|
2019
Q3 | $376K | Buy |
10,659
+5
| +0% | +$173 | ﹤0.01% | 2452 |
|
|
2019
Q2 | $416K | Buy |
10,654
+1,304
| +14% | +$52.6K | ﹤0.01% | 2437 |
|
|
2019
Q1 | $414K | Buy |
9,350
+580
| +7% | +$22.1K | ﹤0.01% | 2405 |
|
|
2018
Q4 | $306K | Buy |
8,770
+3,129
| +55% | +$99.1K | ﹤0.01% | 2535 |
|
|
2018
Q3 | $207K | Buy |
+5,641
| New | +$173K | ﹤0.01% | 2712 |
|
Other funds holding KIDS
B
GIM
SCM
WA
RhumbLine Advisers's KIDS Position: Q2 2026 in Review
RhumbLine Advisers increased its OrthoPediatrics (KIDS) stake by 2.3% in Q2 2026, buying an estimated $8.27K and bringing the position to 21,186 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.
RhumbLine Advisers first reported a position in KIDS in Q3 2018 and has held it in 32 quarters since. The position peaked at $915K in Q2 2023. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.
- RhumbLine Advisers held 21,186 shares of OrthoPediatrics worth $405K as of Q2 2026.
- RhumbLine Advisers bought 476 OrthoPediatrics shares in Q2 2026, an estimated $8.27K.
- OrthoPediatrics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2892 holding.
- RhumbLine Advisers first reported a position in OrthoPediatrics in Q3 2018 and has held it in 32 quarters since.
- RhumbLine Advisers's OrthoPediatrics position peaked at $915K in Q2 2023.
- 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.